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Chemicals and materials 
Angiotensin I (trifluoroacetate salt, 98%), was obtained from Bachem (Dübendorf, 
Switzerland). Cytochrome C from horse heart (≥90%), 1,2-dichloroethane (DCE, ≥99.5%) and 
1,4-benzoquinone (≥99.5%) were purchased from Fluka (Buchs, Switzerland). Trypsin (from 
bovine pancreas) was obtained from Applichem (Darmstadt, Germany). ACTH (1-24, human) 
was purchased form AnaSpec (Fremont, CA, USA). Bovine β- lactoglobulin (A+B, 90%), DL-α-
tocopheryl acetate (≥96 %), tyrosine-tyrosine hydrochloride, lysine-valine hydrochloride, acetyl-
L- lysine, DL-dithiothretiol (≥99.0%) were purchased from Sigma-Aldrich (Buchs, Switzerland). 
Acetic acid (99.5%) and ammonium bicarbonate (99.5%) were purchased from Fluka (Buchs, 
Switzerland). Methanol (99.9%), tetradecane (≥99.0%), and perfluorodecalin (95%) were 
obtained from Sigma-Aldrich (Buchs, Switzerland). For sample solutions and all experiments, 
deionized water produced by an alpha Q-Millipore System (Zug, Switzerland) was used. 
For microchip fabrication polyimide Kapton was purchased from DuPont (Geneva, 
Switzerland), while polyethylene/polyethylene terephalate (PE/PET) composite sheet for 
lamination was obtained from Morane Senator (Oxon, UK). 
During the experiments droplets were generated in the fused silica capillaries (75 µm i.d, 
BGB analytik AG, Böckten, Switzerland) using T-junction (IDEX Health and Science LLC, Oak 
Harbor, WA, USA) and were transferred to the spyhole microchip via a homemade plastic holder 
with tight fittings (IDEX Health and Science LLC, Oak Harbor, WA, USA). The water and DCE 
phases were injected into the capillaries using glass syringes (Hamilton, Bonaduz, Switzerland) 
by the syringe pumps (Cole Palmer Instrument Company, Vernon Hills, USA) at flow rates of 75 
μL/h and 45 μL/h, respectively. 
Mass spectrometer (Thermo LTQ Velos, Thermo Scientific, San Jose, USA) was always 
operated in a positive ion mode. Its ion transfer capillary of was bended for the horizontal 
positioning of the spyhole microchip. ESTASI MS analysis of all the samples was performed 
with 8 kV amplitude and 10 Hz frequency of high voltage pulses. Voltage pulses (0 to 8 kV) 
were generated by a function generator and a high voltage amplifier (10HVA24-P1, HVP High 
Voltage Products GmbH, Martinsried/Planegg, Germany).  
  
SI-1. Microfluidic set-up optimization 
Microchip with a spyhole was fabricated by laser ablation of a polyimide (PI) substrate as 
described elsewhere.[1,2] The thickness of used PI substrate was 125 μm. After drilling a main 
channel, the spyhole was drilled from the same side using a round-shaped mask. Therefore, after 
the PE/PET lamination of the PI substrate on the side with the main channel, the spyhole 
remained open. The microchip design is presented on Figure SI-1.1. 
 
Figure SI-1.1. Microchip with a spyhole. Schemes of a) top and b) longitudinal views of the PI 
microchip with the spyhole. Photos of the spyhole in the microchip when a) the water droplet 
passes it by (light spot in the spyhole), and b) oil plug passes it by (dark spot in the spyhole). The 
photos were made by a laser scanning microscope VK-8710 (Keyence Corporation, Osaka, 
Japan). 
In the laser ablation process, the channel width was fixed by the size of the ablation mask 
used for its drilling. The depth of the microchannel was defined by the speed of the substrate 
translation and was measured by a laser scanning microscope VK-8710 (Keyence Corporation, 
Osaka, Japan). As can be concluded from Figure SI-1.1.b, the depth of the spy hole depended on 
the microchannel depth and microchip thickness. Theoretically, the spyhole diameter should be 
determined by the size of the mask used for its drilling and be the same for inner and outer parts 
of the microchip. However, due to the small size of the mask and laser energy dispersion during 
the ablation process, only the inner diameter of the hole corresponded to the mask dimensions. 
The outer diameter was smaller, than the mask, providing a cone- like shape for the spyhole in 
longitudinal view (Figure SI-1.1.b). 
In order to obtain stable electrostatic spray from the spyhole without any solution leakage, 
such parameters as a spyhole diameter, microchannel depth and width were optimized. Tested 
values of these parameters are presented below in Table SI-1. The values for spyhole diameter 
correspond to the inner diameter defined by the size of the ablation mask. The evaluation of the 
microchip was made based on the ESTASI performance from the continuous sample flow, 
typically of 3 μM angiotensin I in ESI solution at 75 μl/h. The number of electrostatic sprays per 
minute coming out from the spyhole and the minimal value of signal- to-noise (S/N) ratio for 
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single cation current (SCC) of angiotensin I cations were used for ESTASI performance 
description. 
Table SI-1. Tested microchip parameters. 
Channel 
width, μm 
Channel 
depth, 
μm 
Hole 
Diameter, 
μm 
Sprays 
per min 
SCC 
min S/N 
ratio 
Channel 
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Diameter, 
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min S/N 
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-- 
0 -- 
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21.5 
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21.5 30 
50 40 
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50 
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50 7 2 30 
100 
5.5 0 -- 40 
21.5 6 3 50 
For a microchannel width of 200 μm, none of the parameter combinations shown in Table 
SI-1, provided efficient electrostatic spray without solution leakage from the spyhole. Even the 
presence of swab stick at the microchip outlet could not prevent the solution from coming out of 
the spyhole. An example of obtained TCC and SCC chromatograms, as well as an ESTASI MS 
spectrum is shown in Figure SI-1.2. 
 
Figure SI-1.2. Spyhole microchips evaluation by ESTASI performance, example of a leaking 
spyhole. a) TCC and SCC chromatograms, b) ESTASI MS spectrum. Sample: 3 µM angiotensin 
I in ESI solution at 75 µl/h. High voltage frequency: 10 Hz.  
Such microchips displayed poor ESTASI efficiency with ≤6 sprays per minute and low 
minimal S/N ratio for SCC because of the sample solution leakage from the spyhole. Such 
leakage leaded to the formation of a large solution drop difficult to be sprayed and yielding a 
noisy MS spectrum (Figure SI-1.2.b). Therefore, a 100 μm channel width was chosen for further 
experiments. Its combination, along with the microchannel depth of 25 μm, insured the absence 
of solution leakage, but no spray was observed because of the large value of spyhole depth, 100 
μm. Variation of the hole diameter did not provide any improvements in this case. 
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Figure SI-1.3. Spyhole microchips evaluation by ESTASI performance. Inefficient spyhole, 100 
µm main channel width, 50 µm main channel depth and 50 µm spyhole diameter: a) TCC and 
SCC chromatograms, b) ESTASI MS spectrum. Efficient spyhole, 100 µm main channel width, 
100 µm main channel depth and 50 µm spyhole diameter: c) TCC and SCC chromatograms, 
signal frequency of 1.5 Hz, d) ESTASI MS spectrum. Sample: 3 µM angiotensin I in ESI 
solution at 75 µl/h. High voltage frequency: 10 Hz.  
Increasing of the microchannel depth to 50 μm led to the decrease of spyhole depth to 75 
μm and allowed some electrostatic spray when the spyhole diameter was 50 μm, but in an 
inefficient manner with only 7 sprays per min and with minimal S/N ratio for SCC of 2 (Figure 
SI-1.3.a and b). The most efficient and stable electrostatic spray with signal frequency of 1.5 Hz 
was observed only when the microchannel depth was increased to 100 μm, the spyhole depth and 
inner diameter were 25 μm and 50 μm, respectively (Figure SI-1.3.c and d). The outer diameter 
of the spyhole was measured to be between 30 and 40 μm, depending on the microchips 
produced (Figure SI-1.1.d). When swab stick was used for solution collection at the microchip 
outlet, no leakage from the spyhole was observed for this microchip configuration if total flow 
rate of the solution was ≤ 150 µl/h. 
These microchip parameters used for further experiments provided effective sample 
ionization with high detection sensitivity, minimal S/N ratio for SCC of 3000 and RSD for TCC 
and SCC intensities of 15% and 16 % (n=30), respectively. For continuous sample flow at 75 
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µl/h inside the microchip, the limit of detection (value of 3 S/N ratio) by ESTASI MS was 
defined as 5 nM for peptide angiotensin I and 30 nM for protein cytochrome C (Figure SI-1.4). 
 
Figure SI-1.4. Limit of detection for ESTASI MS analysis of continuous sample flow at 75 µl/h 
inside the microchip with a spyhole. a) 5 nM angiotensin I, b) 30 nM of cytochrome C. Sample 
solutions were containing 50% methanol, 49% deionized water, and 1% acetic acid. 
To perform the ESTASI in the system under consideration, voltage square wave pulses 
with the amplitude of 8 kV were normally applied to the electrode placed under the microchip 
using a function generator with a voltage amplifier (10HVA24-P1, HVP High Voltage Products 
GmbH, Martinsried/Planegg, Germany). The typical square wave frequency was 10 Hz, meaning 
that during the first 50 ms (charging of the capacitors) high voltage pulse provoked the 
electrostatic spray of cations and during the last 50 ms electrostatic spray of anions was elicited 
(discharging of the capacitors).[1] It provided for the continuous sample flow the TCC signal with 
average frequency of ~ 1.5 Hz, as displayed in Figure SI-1.3.c. This TCC average signal 
frequency was determined by the combination of the square voltage wave frequency with the 
scanning frequency of the ion trap mass spectrometer (Thermo Scientific, San Jose, USA) 
employed in a positive mode. Taking into account that the maximum ion injection time for the 
ion trap was set to 100 ms following the high voltage frequency of 10 Hz and that an enhanced 
scanning mode (m/z 10000 per second) was used, it took ~ 333 ms for the instrument to generate 
each spectrum for the spray of cations. 
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SI-2: Optimization of droplets formation 
Choice of oil phase 
The choice of oil phase is crucial for coupling the water-in-oil droplet system to the MS 
detection as the oil presence compromises ionization efficiency and ESI plume stability.[3] 
Various components were tried as the oil phase in the present droplet-based system with droplet 
generation frequencies of ~0.5 Hz that are listed in Table SI-2. It is worth mentioning that prior 
to any oil injection into the main channel of the microchip, it was treated with Aquapel, 
commercial water repellant, for surface hydrophobization and better oil adhesion. 
Table SI-2. Oil phase used for droplets formation. 
Compound 
Tetradecane 
(TD) 
Perfluorodecalin 
(PFD) 
1,2-dichloroethane 
(DCE) 
Dynamic viscosity at 25ºC, mPa·s 
Methanol for comparison: 0.56 
2.1 5.1 0.78 
Droplets frequency: 
0.5 Hz 
Sprays per min -- 6 20 
SCC min S/N ratio -- ≤1.5 50 
Long carbon chain compounds, like TD, introduced as an oil phase at 30 µl/h quenched 
ESTASI. Therefore, no ESTASI MS signal was observed from droplets containing 3 µM 
angiotensin I in ESI solution introduced as aqueous phase at 15 µl/h. Viscosity of this compound 
is much higher than for traditional ESI solvents such as methanol (Table SI-2) and significantly 
compromises electrostatic spray. PFD is widely used as oil phase for droplet-based microfluidics 
with ESI MS detection due to its low interference with the ESI plume[3–6] and was tried as an oil 
phase for spyhole ESTASI MS system as well. Droplets were generated with PFD introduced as 
an oil phase at 30 µl/h, while the water phase was introduced at 15 µl/h. Obtained results are 
presented in Figure SI-2.1. 
 
Figure SI-2.1. Spyhole ESTASI of water- in-PFD droplets. a) TCC and SCC chromatograms, b) 
ESTASI MS spectrum. Sample: 3 µM angiotensin I in ESI solution. Oil and water phase rates: 
30 µl/h and 15 µl/h, respectively. High voltage frequency: 10 Hz. Droplets frequency ~0.5 Hz.  
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PFD as the oil phase did not quench the electrostatic spray from the spyhole and provided 
MS spectra with sufficient signal intensity, but the spray was unstable and displayed only 6 
sprays per minute. As the outer diameter of the spyhole was only 30 µm, PFD still influenced 
significantly the plume formation. 
DCE is a very well known solvent immisible in water, widely used for physicochemical 
studies of various processes at liquid- liquide interfaces,[7–9] including the creaction of 
biomembrane mimetic model to study the trans-cell membrane biological reactions.[10,11] DCE 
possesses the lowest viscosity among tested compounds with a value of 0.78 mPa·s, close to 
methanol with 0.56 mPa·s and is immiscible with water; therefore, it was also tried as the oil 
phase and showed the best spyhole ESTASI performance for droplets generated with 0.5 Hz 
frequency (Figure SI-2.2). DCE was introduced into the T-junction at 80 µl/h along with the 
water phase at 50 µl/h. 
 
Figure SI-2.2. Spyhole ESTASI of water- in-DCE droplets. a) TCC and SCC chromatograms, b) 
ESTASI MS spectrum. Sample: 3 µM angiotensin I in ESI solution. Oil and water phase rates: 
80 µl/h and 50 µl/h, respectively. High voltage frequency: 10 Hz. Droplets frequency ~0.5 Hz.  
With DCE as oil phase the number of sprays per minute increased to 20 and minimal S/N 
ratio for SCC was giving a value of 50, so this solvent was chosen for further experiments with 
droplets. The issues with the reproducibility of TCC, SCC, MS signal intensities and spray 
stability were further addressed and resolved as described below in the section Droplet frequency 
optimization. 
Prior to the optimization of droplets generation, DCE was tested on the possible sample 
diffusion into such oil phase, as it is more polar than conventional oil phases, like PFD or TD. 
For this purpose, a shake flask experiment was performed separately for the following 
compounds used further in the present work: 3 µM angiotensin I, 10 µM cytochrome C, 10 µM 
human ACTH (1-24), 5.4 µM β- lactoglobulin (A and B isoforms) and 5 µM peptide TVSFNF. 
200 µl of water solution of each compound was brought into contact with 200 µl of DCE in a 0.5 
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ml eppendorf tube, which was then vortexed for 3 min. Subsequently, the emulsion of 
water/DCE was centrifuged at 10000 g for 30 sec for better separation of the phases; each phase 
was then spotted separately on a MALDI plate and dried at the room temperature. After matrix 
solution addition and spots drying, MALDI MS analysis of water and DCE phases was 
performed to check the presence of the compound of interest. For peptide MALDI MS analysis 
10 mg/ml solution of 2,5-dihydroxybenzoic acid in 50% acetonitril, 49.9% water, 0.1% 
trifluoroacetic acid was used, while 2 mg/ml sinapinic acid solution in 70% acetonitril, 29.9% 
water, 0.1% trifluoroacetic acid was used for the proteins. 
 
Figure SI-2.3. MALDI MS spectra of DCE polarity test on sample diffusion. Sample: a) 3 µM 
angiotensin I, b) 10 µM cytochrome C, c) 10 µM human ACTH (1-24), d) 5.4 µM β-
lactoglobulin (A+B) and e) 5 µM peptide TVSFNF. Blue spectra represent the water phase 
content before shake-flask experiment, while red and black spectra correspond to after-shake-
flask experiment content of water and oil phases, respectively.  
MALDI MS detection was chosen for this experiment in order to analyze the DCE phase, 
as in the ESI MS this solvent is very difficult to be ionized and does not give any signal. As can 
be concluded from the obtained results of shake-flask experiment, none of the tested compounds 
diffused to the DCE phase: peptides and proteins were observed only in the water phase. Even 
hydrophobic peptide, such as TVSFNF, for which the stock solution contained 50% methanol to 
increase its solubility in water, did not diffuse into the DCE phase and was observed only on the 
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MALDI MS spectrum of the aqueous phase (Figure SI-2.3.e). DCE application as the oil phase 
does not lead to sample diffusion into this phase; therefore, this solvent was used for further 
experiments. 
Droplet frequency optimization 
In the case of water- in-oil droplets coupling with ESTASI MS via the described 
microchip, the synchronization between droplet generation frequency, voltage pulse frequency 
and MS scans would provide the advantage of avoiding voltage application to the oil segments 
and energy saving. To achieve synchronization, it was required that the high voltage activation 
occurred only when the water droplet was under the spyhole. In the described experiments, we 
have tried manually to realize the synchronization by droplets visual control using a portable 
digital microscope (Dino-Light, Amno, Taiwan); however, it remained challenging. Therefore, 
the frequencies ≤0.5 Hz, significantly lower than 1.5 Hz (spyhole ESTASI signal frequency from 
the continuous sample flow, SI-1) were chosen for droplet generation to insure by default the 
ionization and detection of all formed droplets, to have preferably one spray per droplet and 
providing sufficient time between two droplets for the MS instrument to respond on the sample 
electrostatic spray and finish the measurement. 
As presented in Figure SI-2.2, the TCC and SCC (RSD=60%, n=20) signals from water-
in-DCE droplets formed with 0.5 Hz frequency were unstable, potentially due to the absence of 
the good matching with the timing of high voltage pulses. Lower frequencies of 0.3 Hz and 0.1 
Hz were also tried for droplet generation. For 0.3 Hz DCE was injected at 60 µl/h and the water 
phase was introduced at 75 µl/h. For 0.1 Hz DCE was injected at 45 µl/h and aqueous was 
introduced at 75 µl/h. Obtained results are shown in Figure SI-2.4. 
 
Figure SI-2.4. Spyhole ESTASI of water-in-DCE droplets. Droplets frequency: a) 0.3 Hz and b) 
0.1Hz. Sample: 3 µM angiotensin I in ESI solution. High voltage frequency: 10 Hz. 
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For droplet generation frequency of 0.3 Hz better reproducibility for TCC and SCC 
intensities (RSD=30%, n=20) was obtained, however, signal frequency was still unstable. The 
droplet generation frequency of 0.1 Hz provided the most stable TCC (RSD=16%, n=20) and 
SCC (RSD=15%, n=20) signals simultaneously with a stable signal frequency (0.1 Hz, RSD=5%, 
n=20) in accordance with the droplet generation frequency. As the high voltage frequency was 
10 Hz, it took 50 ms to apply the voltage pulse for positive electrostatic spray. Meanwhile, for a 
droplet generated at 0.1Hz frequency (average volume of 3 nl, RSD=7%, n=20) and flow rate of 
120 µl/h it took ~100 ms to pass by the spyhole, indicating that part of the droplet (≤50%) was 
submitted to the high voltage pulse. Therefore, there was a good matching between droplets and 
high voltage frequencies, which insured only one electrostatic spray per droplet and provided 
reproducible TCC and SCC signals. 0.1 Hz was chosen as a working frequency for further 
experiments. 
  
SI-3: Sample carry-over experiment for spyhole ESTASI 
To check the sample carry-over in the spyhole microchip the concentration gradient was 
created in the droplets using  5 μM acetyllysine (AcLys) solution (A) and 5 μM dipeptide TyrTyr 
solution (B). 5 μM of dipeptide LysVal was presented in both solutions as an internal standard to 
perform the relative quantification of ESTASI MS results. The gradient of two solutions for 
water phase was made using liquid chromatography (LC) pump Accela Thermo (Thermo 
Scientific, San Jose, USA). The gradient program was set to change the ratio between solution A 
and B from 100:0 to 0:100 within 5 min. The flow rate for LC pump was set to 100 μl/min and 
was decreased to 1.25 μl/min (75 μl/h) using a Micro-Splitter valve (IDEX Health and Science 
LLC, Oak Harbor, WA, USA) prior to the introduction to the T-junction as the aqueous phase. 
DCE was introduced as the oil phase at 45 μl/h. Before starting the gradient program, the system 
was flushed with solution A for 3 min to insure stab le droplets formation. The experiment was 
performed in triplicates. Obtained SCC chromatograms for AcLys, TyrTyr and internal standard 
LysVal, as well as corresponding ESTASI MS spectra, are presented in Figure SI-3. 
Figure SI-3. Carry-over experiment for spyhole ESTASI with AcLys-TyrTyr concentration 
gradient. a) SCC chromatograms for AcLys, TyrTyr and LysVal as internal standard. b) ESTASI 
MS spectra corresponding to the following moments of the gradient program for A and B 
solutions: 0.04 min (100:0), 0.99 min (80:20), 2.02 min (60:40), 3.05 min (40:60), 4.05 min 
(20:80)and 5.3 min (0:100). 
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It is worth mentioning that in general the ionization efficiency for AcLys is lower than 
for TyrTyr. As can be observed on ESTASI MS spectra (Figure SI-3.b) for time of 0.04 min 
corresponding to pure 5 μM AcLys solution with internal standard and for time of 5.3 min 
corresponding to pure 5 μM TyrTyr with internal standard, TyrTyr peak intensity is the same as 
for LysVal, while for AcLys the peak intensity is two times lower. 
As displayed in Figure SI-3, the droplet frequency was ~0.1Hz and for the internal 
standard LysVal, whose concentration remained constant during the experiment, RSD for the 
SCC intensity was 17% (n=20). SCC chromatogram profiles of AcLys and TyrTyr followed the 
gradient program, as can be also be concluded from the corresponding ESTASI MS spectra 
(Figure SI-3.b). For the gradient time 5.3 min corresponding to 0% of solution A and 100% of 
solution B small peak of AcLys can still be observed on the ESTASI MS spectrum at the level of 
the detection limit and shows the carry-over of 6 % for the SCC signal. No leakage from the 
spyhole was observed during this experiment neither visually, nor on the SCC chromatograms 
(no high noise level was observed in contrast with the example of leaking spyhole, Figure SI-1.2). 
Therefore, the carry-over arises mainly from the sample adsorption inside the microfluidic 
system and LC pump. 
  
SI-4: Tryptic digestion in droplets 
 
Figure SI-4. ESTASI MS spectra of the tryptic digestion in droplets at 25⁰C and in the bulk 
solution at 37⁰C for a) 10 µM peptide ACTH (1-24) and b) 10 µM protein cytochrome C 
digestion with trypsin concentration of 5µg/ml, including the spectra of intact molecules 
collected prior to the enzymatic reaction. ESTASI MS spectra collected at various reaction times 
during tryptic digestion in the droplets: c) 10 µM peptide ACTH (1-24) digestion and d) 10 µM 
protein cytochrome C digestion. Reaction time was defined as the time needed for freshly 
formed droplets to pass from the T-junction to the spyhole inside the microchip. 
Obtained ESTASI MS data confirm that the tryptic digestion in droplets is much faster 
than in the bulk solution. ACTH digestion in the developed droplets-based microfluidic system 
was completed in 13 min at 25⁰C, while it took 4 h to obtain the same results for bulk solution 
digestion performed at 37⁰C. In-droplets enzymatic digestion of cytochrome C was finished in 
32 min in contrast to 15 h for bulk reaction. Peptides observed on the ESTASI MS spectra for in-
droplets and bulk solution digestions of ACTH and cytochrome C are presented below in the 
Tables SI-4.1 and SI-4.2 respectively. 
ESTASI MS results of performed in-droplets tryptic digestion show the possibility to 
efficiently perform such single-phase reactions using developed spyhole microfluidic system. 
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Table SI-4.1. Peptides identified by ESTASI MS during ACTH digestion by trypsin 
 
1.
Presented sequences of identified peptides include the main amino acid sequence and the amino acids before and 
after the place of cleavage by trypsin in parentheses. The peptide sequences are identified by comparison of 
observed peptide molecu lar weights with theoretical ones using the FindPept tool on the ExPASy server 
(http://web.expasy.org/findpept/). 
2.
(-) means that the peptide is generated from a terminal of the peptide. 
3.
Peptide contains oxidized methionine residue. 
 
 
 
 
 
 
Observed peaks after 
digestion, m/z Charge 
state, z 
Molecular 
weight, Da 
Peptide sequence  
Missed 
cleavages Droplets in 
13 min 
Bulk solution in 
4h 
‒ 250.4 2 498.8 (R)RPVK(V)1 0 
303.4 303.8 1 302.6 (K)KR(R)
 
1 
328.3 328.7 2 655.1 (K)RRPVK(V) 1 
378.4 378.8 1 377.6 (K)VYP(-)
2 
0 
386.3 386.7 2 771.0 (R)WGKPVGK(K) 1 
429.2 430.1 2 857.3 (R)RPVKVYP(-) 2 
450.3 450.8 2 899.2 (R)WGKPVGKK(R) 1 
499.4 499.3 1 498.4 (R)RPVK(V) 1 
507.7 508.0 2 1013.8 (K)RRPVKVYP(-) 2 
528.8 528.9 2 1055.7 (R)WGKPVGKKR(R) 2 
536.8 537.0 2 1071.8 (-)SYSMEHFR(W)
3 
0 
571.3 571.8 2 1142.7 (K)KRRPVKVYP(-) 3 
655.5 ‒ 1 654.5 (K)RRPVK(V) 1 
771.6 771.6 1 770.6 (R)WGKPVGK(K) 0 
392.1 ‒ 2 783.5 (K)KRRPVK(V) 2 
858.6 858.7 1 857.6 (R)RPVKVYP(-) 2 
1014.7 ‒ 1 1014.6 (K)RRPVKVYP(-) 2 
1056.6 1056.6 1 1055.6 (-)SYSMEHFR(W) 0 
1072.6 ‒ 1 1071.6 (-)SYSMEHFR(W)3 0 
Table SI-4.2. Peptides identified by ESTASI MS during cytochrome C digestion 
Observed peaks after 
digestion, m/z Charge 
state, z 
Molecular 
weight, Da 
Peptide sequence  
Missed 
cleavages Droplet in 
32 min 
Bulk solution 
in 15 h 
262.2 262.5 1 261.4 (K)GGK(H)
1 
0 
332.3 332.1 1 332.2 (K)GKK(I) 1 
390.2 390.5 2 778.7 (K)MIFAGIK(K) 0 
404.7 405.1 1 403.9 (K)TER(E) 0 
434.7 434.8 1 433.8 (K)ATNE(-)
2 
0 
455.2 455.2 2 908.5 (K)MIFAGIKK(K) 1 
478.5 479.1 3 1433.7 (K)HKTGPNLHGLFGR(K) 1 
‒ 518.3 2 1035.6 (K)MIFAGIKKK(T) 2 
562.8 563.8 1 562.0 (K)KATNE(-) 1 
585.6 585.7 2 1169.4 (K)TGPNLHGLFGR(K) 0 
634.6 635.0 1 633.8 (K)IFVQK(C) 0 
648.5 648.3 2 1296.7 (K)TGPNLHGLFGRK(T) 1 
661.1 ‒ 1 661.4 (K)KKTER(E) 2 
678.7 678.7 1 677.7 (K)YIPGTK(M) 0 
734.8 735.2 2 1470.7 (K)TGQAPGFTYTDANK(G) 0 
740.4 740.5 2 1478.9 
(K)TEREDLIAYLKK(A) or 
(K)KTEREDLIAYLK(K) 
2 
‒ 748.9 2 1495.7 (K)EETLMEYLENPK(K) 0 
‒ 761.9 1 762.5 (K)KIFVQK(C) 1 
779.8 779.7 1 778.7 (K)MIFAGIK(K) 0 
800.3 800.5 2 1598.8 (R)KTGQAPGFTYTDANK(N) 1 
806.2 ‒ 1 806.5 (K)KYIPGTK(M) 1 
‒ 818.1 2 1634.2 (K)IFVQKCAQCHTVEK(G) 1 
‒ 839.8 2 1677.7 (K)GGKHKTGPNLHGLFGR(K) 2 
857.5 ‒ 2 1713.0 (K)TGQAPGFTYTDANKNK(G) 1 
907.7 907.8 1 906.7 (K)MIFAGIKK(K) 1 
921.5 921.4 2 1840.9 (R)KTGQAPGFTYTDANKNK(G) 2 
1041.4 1041.8 2 2081.3 (K)GITWKEETLMEYLENPK(K) 1 
1105.8 1105.8 2 2209.7 (K)GITWKEETLMEYLENPKK(Y) 2 
1.
Presented sequences of identified peptides include the main amino acid sequence and the amino acids before and 
after the place of cleavage by trypsin in parentheses. The peptide sequences are identified by comparison of 
observed peptide molecu lar weights with theoretical ones using the FindPept tool on the ExPASy server 
(http://web.expasy.org/findpept/). 
2.
(-) means that the peptide is generated from a terminal of the protein. 
 
 
SI-5: β-lactoglobulin and α-tocopheryl acetate interaction 
 
Figure SI-5. ESTASI MS spectra of β- lactoglobulin (LGB) and α-tocopheryl acetate (TA) 
biphasic interaction in droplets: 5.4 µM LGB (A+B) in the water phase and 135 µM TA in DCE. 
Double peak observed for each LGB charge state corresponds to the two isoforms (A+B). a) MS 
spectra from the droplets at various reaction times. Reaction time was defined as the time needed 
for freshly formed droplets to pass from the T-junction to the spyhole inside the microchip. b) 
Time dependence of the ratio between MS peak intensities of TA and OxTA. c) Time 
dependence of the ratio between LGB MS peak intensities for charge states z=10 and z=13. The 
red point corresponds to the moment when aggregation of reduced LGB already occurs. 
During the biphasic reaction (Figure SI-5.a) LGB changed its charge distribution on MS 
spectra from normal (1) to the intermediate (2) and finally to the one of the reduced molecule (3), 
while TA was oxidized (4). The progress of this redox reaction can be followed by comparing 
the MS peak intensities of TA and oxidized TA (OxTA) at various reaction times. As displayed 
in Figure SI-5.b, the TA/OxTA ratio was decreasing with time indicating TA oxidation. At the 
same time, the ratio between LGB MS peak intensities for charge states z=10 and z=13 was 
increasing with the reaction progress until reduced LGB started to aggregate (red point, Figure 
SI-5.c). This shows the reduction of LGB as the peak with charge state z=13 is predominant for 
the native protein molecule, while the peak with charge state z=10 is predominant for the 
reduced LGB. 
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SI-6: Tandem MS analysis of α-tocopherolyl acetate and its oxidation product 
 
Figure SI-6. Tandem MS analysis of α-tocopheryl acetate (TA) and its oxidation product. a) 
ESI-MS spectrum of TA (M+= 473.3 Da) and its oxidized form (M+= 490.2 Da) obtained during 
the reaction with LGB in the shake flask reaction. b) MS-MS spectrum of the intact TA ion, M+= 
473.3 Da, fragmented via collision induced dissociation (CID). c) MS-MS spectrum of the 
oxidized TA ion, M+= 490.2 Da, fragmented via CID. Fragmentation of the molecules is 
schematically shown on their chemical structures. A: acetic group. 
TA interaction with LGB leads to its oxidation and the formation of oxidized TA. 
Performance of MS/MS analysis allows identification of the oxidized TA structure. As can be 
concluded from the obtained MS/MS spectrum of the intact TA ion, M+ = 473.3, presented above, 
during its CID fragmentation the acetic group (MW = 42 Da) was easily lost forming the 
fragment ion M+ = 431.1. Consequently, this ion lost the fatty tail (MW = 225 Da) and formed 
the ion M+ = 206.8. The absence of fatty tail provoked further loss of a part of the molecule (MW 
= 41 Da) and formation of ion M+= 165.1 Da, as indicated on Figure SI-6.b. 
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Similar behavior was observed for the CID fragmentation of oxidized TA ion, M+ = 490.2. 
The loss of the acetic group (MW = 42 Da) led to formation of the ion M+ = 448.1, which further 
gave the ion M+ = 430.1 by losing a water molecule. However, this process (dashed blue arrows 
on the Figure SI-6.c) was less efficient than the direct loss of H2O molecule from the intact 
oxidized TA, which provided the fragmentation ion M+ = 472.3. Then this ion lost easily the 
acetic group, forming the same ion M+= 430.1 Da (solid blue arrows on the Figure SI-6.c). 
Meanwhile, there was a third fragmentation process, which did not include the loss of the 
acetic group (solid red arrows on the Figure SI-6.c). It started from the loss of the fragment with 
MW = 32 Da forming the ion M+ = 458.1. Then this ion lost a fragment with MW = 56 Da 
providing the ion M+ = 401.7. Such a fragmentation pathway is possible only because of the 
presence of the acetic group in the oxidized TA and provides evidence towards the proposed 
chemical structure of this molecule and TA oxidation due to the interaction with LGB. 
  
SI-7: Tagging free cysteine residues in the reduced β-lactoglobulin with 
benzoquinone 
Each isoform (A or B) of the native β- lactoglobulin (LGB) molecule possesses one free 
cysteine residue,[1] which can be tagged by benzoquinone (BQ). To perform this control reaction, 
the water droplets containing LGB and BQ were generated and transferred inside the microchip 
with the spyhole without adding α-tocopheryl acetate (TA) to the DCE phase. The ESTASI MS 
spectra obtained from these water droplets are presented below in Figure SI-7.1. 
 
Figure SI-7.1. Tagging free cysteine residue by 2.5 mM BQ in the native LGB (A and B 
isoforms, 5.4 μM). ESTASI MS spectra of pure native LGB (black spectra) and native LGB 
tagged with BQ (red spectra). The zoomed region represents the LGB peaks with charge states 
z=16 and z=15 to show the mass-to-charge (m/z) shift due to one tag by BQ for both protein 
isoforms. nH+: n protonated ions; A(B)-nH+ & 1tag: n protonated A (B) isoform of LGB with 
one BQ tag. 
As a mixture of LGB isoforms A and B was used, two series of peaks corresponding to 
isoforms B and A were always presented for every charge state. BQ, MW= 108 Da, tagged one 
free cysteine residue in each LGB isoform and a clear m/z shift related to the addition of 108 Da 
(one BQ tag) was observed for both isoforms (Figure SI-7.1, zoomed region). 
The native LGB molecule (each isoform) includes two disulfide bridges,[12] which would 
lead to the formation of four free cysteine residues after reduction by TA. To check the 
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appearance of additional free cysteine residues in the LGB molecule due to its reduction by TA, 
the water droplets containing LGB were generated in the presence of TA and BQ in the DCE 
phase, as BQ is more soluble in oil phase. ESTASI MS spectra obtained from these droplets are 
shown below in Figure SI-7.2. 
 
Figure SI-7.2. Tagging free cysteine residues by 2.5 mM BQ in the LGB (A and B isoforms, 5.4 
μM) reduced by 135 μM TA. a) Full ESTASI MS spectra of TA reduced LGB (black spectrum) 
and TA reduced LGB tagged with BQ (red spectrum). b) Magnified region represents LGB 
peaks with charge states z=14 and z=13 to show m/z shifts due to one or two tags by BQ for both 
protein isoforms. c) Deconvoluted spectra of TA reduced LGB (black spectrum) and TA reduced 
LGB tagged with BQ (red spectrum). A(B)-nH+: n protonated A (B) isoform of LGB; A(B)-nH+ 
& 1 (2) tag(s): n protonated A (B) isoform of LGB with one (two) BQ tag(s). 
Besides the m/z shift corresponding to the addition of 108 Da due to one BQ tag, another 
m/z shift related to the addition of 216 Da owing to two BQ tags, was found for both LGB 
isoforms (Figure SI-7.2.b) and was not previously observed for the native protein. On the 
deconvoluted ESTASI MS spectra LGB peaks corresponding to the addition of two BQ tags are 
clearly observed (Figure SI-7.2.c). The presence of a second BQ tag in the LGB molecule is 
possible only if additional free cysteine residues are present in the protein structure as a result of 
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disulfide bridge reduction by TA. This fact further proves the idea of redox reaction between 
LGB and TA. 
Considering the peaks of LGB isoforms with more than two BQ tags, they were difficult 
to observe on MS spectra owing to their lower abundance, lower intensities and the high noise 
level created by excess of BQ in the water droplets. One of the possible reasons for the low 
abundance of multiple BQ tags is the occurrence of side reaction between TA and BQ, as the 
later compound is added to the oil phase in a large excess in comparison with LGB and TA. 
Therefore, BQ could oxidize TA as well, decreasing the rate of LGB-TA redox reaction and 
explaining the charge distribution of LGB molecule observed in ESTASI MS spectrum in Figure 
SI-7.2.a, red line. The presence of two BQ tags indicates that LGB is reduced by TA, but only 
partially, still providing the charge distribution of a native protein molecule. 
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